Chaihu saponin A is a core triterpenoid saponin extracted from the traditional Chinese medicine Chaihu (Bupleurum). It exerts anti-inflammatory, hepatoprotective, and anti-tumor effects by regulating the TNF-α/NF-κB inflammatory pathway and the Bcl-2/Bax apoptotic pathway. Its unique molecular structure can penetrate the blood-brain barrier, with an oral bioavailability of about 12%. It is suitable for adjuvant therapy of viral hepatitis, depression, and tumor chemotherapy sensitization.
Frequently Asked Questions
Q1: What is the purity of Saikosaponin a Powder?
A: The assay of our Saikosaponin a is ≥99% as tested by HPLC, ensuring pharmaceutical grade quality.
Q2: What are the primary storage requirements?
A: Storage methods are negotiable based on packaging, but it is generally recommended to keep in a cool, dry place away from light.
Q3: Can Saikosaponin a cross the blood-brain barrier?
A: Yes, its unique molecular structure allows it to penetrate the blood-brain barrier, making it effective for neuroprotective research.
Q4: What is the typical shelf life of this product?
A: The product maintains its stability and activity for more than 12 months under proper storage conditions.
Q5: What is the monthly production capacity for Saikosaponin a?
A: We have a stable production capacity of approximately 100kg per month to meet bulk requirements.
Q6: What specific applications is this ingredient used for?
A: It is widely used in pharmaceutical research, traditional Chinese medicine formulations, and adjuvant therapy studies for liver and immune health.